It has been shown that T cells are inhibited by tumor-produced extracellular ADO because of the A2AR-triggered elevation of intracellular levels of cAMP and subsequent TCR signaling and IFN-γ production [136]. This evidence concerns the gene ADORA2A and neoplasm.